CLOV Classe A Clover Health Investments, Corp. - Class A Common stock
NASDAQ · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 7, 2026
$4,38
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,58minimo 52 sett.
$5,59massimo 52 sett.
P/E
-5.1
EPS
$-0.44
Ricavi
$1.92B
i tuoi badge
Intervallo 52 sett.
$2–$6
Rating Analisti
BUY
Prezzo Obiettivo
$5
P/E
-5.1
ROE
-26.2%
Margine di Profitto Netto
-0.74%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CLOV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.38
P/E
-5.1
EPS
$-0.44
Ricavi
$1.92B
ROE
-26.2%
Intervallo 52 sett.
$2–$6
CLOV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$1.92B2022-12-31 → 2025-12-31
EPS$-0.442022-12-31 → 2023-12-31
Flusso di cassa libero$-69M2022-12-31 → 2025-12-31
Margine netto-0.74%2022-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CLOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -5.1media 5 anni ≈-4.7 | ≈-4.7 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CLOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -0.74%media 5 anni ≈-6.0% | ≈-6.0% | 3.5% | In linea | |
| Margine EBITDA (TTM) | -0.81%media 5 anni ≈-6.2% | ≈-6.2% | 3.7% | In linea | |
| Pretax Margin (Margine ante imposte) | -4.5% | · | 2.8% | Debole | |
| Margine di Profitto Netto (TTM) | -0.74%media 5 anni ≈-6.0% | ≈-6.0% | 2.9% | Di prim'ordine | |
| ROA | -15.2%media 5 anni ≈-18.9% | ≈-18.9% | 3.0% | Debole | |
| ROE | -26.2%media 5 anni ≈-36.3% | ≈-36.3% | 10.1% | Debole | |
| ROIC | -27.7% | · | 8.0% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CLOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.5media 5 anni ≈1.6 | ≈1.6 | 1.7 | Bassa liquidità | |
| Quick Ratio | 0.4media 5 anni ≈0.6 | ≈0.6 | 1.3 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | CLOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 40.3%media 5 anni ≈21.4% | ≈21.4% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 20.6%media 5 anni ≈13.8% | ≈13.8% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 23.4% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | CLOV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 3.4media 5 anni ≈3.0 | ≈3.0 | 2.4 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$2.7M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
41.1%
Prossimo report
Nov 02, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 3, 2026 | $0.05 | $0.03 | 47.1% |
| 31 Marzo 2026 | $0.07 | $0.03 | 128.8% | |
| 31 Dicembre 2025 | $-0.10 | $-0.11 | 5.1% | |
| 30 Settembre 2025 | $-0.05 | $-0.03 | -63.4% | |
| 30 Giugno 2025 | $-0.02 | $-0.03 | 28.8% | |
| 31 Marzo 2025 | $0.00 | $-0.06 | 100.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | $462M | |
| Gross Profit | · | · | $257M | $70M | $-79M | · | · | |
| SG&A Expense | $214M | $176M | $183M | $204M | $185M | $121M | $96M | |
| Operating Expenses | $2.01B | $1.42B | $1.47B | $1.38B | $2.11B | $766M | $645M | |
| Operating Income | $-86M | $-46M | $-205M | $-287M | $-637M | $-93M | $-183M | |
| Interest Expense | · | · | $7.0K | $1M | $3M | $36M | $23M | |
| Interest Income | · | · | · | · | · | $117.3K | · | |
| Pretax Income | $-86M | $-43M | $-213M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | $-364M | |
| EPS (Basic) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| EPS (Diluted) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| Shares (Basic) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| Shares (Diluted) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| EBITDA | $-87M | $-48M | $-213M | $-372M | $-637M | $-7M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $195M | $123M | $104M | $300M | $92M | $68M | |
| Short-term Investments | · | · | · | · | · | $0 | · | |
| Prepaid Expense | $18M | $13M | $14M | $18M | $15M | $8M | $0 | |
| Other Current Assets | $11M | $16M | $19M | $4M | $3M | $299.0K | · | |
| Current Assets | $308M | $343M | $428M | $625M | $753M | $190M | $0 | |
| PP&E (Net) | $6M | $5M | $5M | $6M | $2M | $2M | · | |
| PP&E (Gross) | $14M | $11M | $10M | $8M | $5M | $4M | · | |
| Accum. Depreciation | $8M | $6M | $5M | $2M | $2M | $2M | · | |
| Goodwill | · | · | $0 | $12M | $1M | $1M | · | |
| Other Non-current Assets | $24M | $13M | $14M | $16M | $10M | $9M | · | |
| Total Assets | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Accounts Payable | $36M | $35M | $37M | $32M | $28M | $31M | · | |
| Accrued Liabilities | · | · | · | · | · | $5M | $0 | |
| Current Liabilities | $209M | $214M | $261M | $432M | $372M | $164M | $118.0K | |
| Capital Leases | · | · | $3M | $4M | $5M | $6M | · | |
| Other Non-current Liabilities | $23M | $26M | $23M | $16M | $14M | $13M | · | |
| Total Liabilities | $232M | $240M | $284M | $452M | $411M | $433M | $118.0K | |
| Long-term Debt | · | · | · | · | $20M | $127M | · | |
| Total Debt | · | · | · | $0 | $20M | · | · | |
| Paid-in Capital | $2.68B | $2.58B | $2.46B | $2.32B | $2.15B | $412M | $0 | |
| Retained Earnings | $-2.29B | $-2.20B | $-2.16B | $-1.95B | $-1.62B | $-1.03B | $-17.6K | |
| Treasury Stock | $86M | $31M | $13M | $7M | $147.0K | $0 | · | |
| AOCI | $528.0K | $-2M | $-2M | $-9M | $-2M | $10.0K | · | |
| Stockholders' Equity | $309M | $341M | $286M | $357M | $540M | $-613M | $-17.6K | |
| Liabilities + Equity | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Shares Outstanding | · | · | · | · | 470,852,394 | 89,206,266 | · |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $-2M | $-3M | $-4M | $-2M | $200.0K | $-195.0K | $-3M | |
| Stock-based Comp | $104M | $114M | $141M | $164M | $164M | $7M | $3M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $2.0K | $2.0K | |
| Amort. of Intangibles | · | · | · | $100.0K | $700.0K | · | · | |
| Restructuring | · | $288.0K | $10M | $0 | · | · | · | |
| Other Non-cash | $-83M | $-34M | $-39M | $-28M | $142M | · | · | |
| Operating Cash Flow | $-67M | $35M | $-145M | $-204M | $-282M | $-118M | $-160M | |
| CapEx | $2M | $2M | $584.0K | $4M | $723.0K | $693.0K | $23.0K | |
| Investing Cash Flow | $4M | $565.0K | $140M | $95M | $-435M | $137M | $-182M | |
| Stock Issued | $1M | $193.0K | $1M | $0 | $284M | $0 | $0 | |
| Stock Repurchased | $18M | $2M | $0 | $0 | $147.0K | $0 | $0 | |
| Net Stock Activity | $-17M | $-2M | $-6M | $-6M | $284M | $25.0K | · | |
| Financing Cash Flow | $-53M | $-17M | $-5M | $-5M | $925M | $6M | $334M | |
| Net Change in Cash | $-116M | $18M | $-10M | $-114M | $208M | $25M | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-69M | $33M | $-116M | $-208M | $-283M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 12.7% | 0.65% | -5.4% | · | · | |
| Operating Margin | -4.4% | -3.3% | -10.2% | -10.7% | -43.3% | · | · | |
| Net Margin | -4.5% | -3.1% | -10.5% | -9.8% | -39.9% | · | · | |
| Pretax Margin | -4.5% | · | · | · | · | · | · | |
| EBITDA Margin | -4.5% | -3.5% | -10.4% | -10.7% | -43.3% | · | · | |
| ROA | -15.2% | -7.5% | -34.0% | -28.6% | -61.8% | -1.6% | · | |
| ROE | -26.2% | -12.6% | -70.2% | -91.6% | 1511.3% | -134.9% | · | |
| ROIC | -27.7% | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.6 | 1.6 | 1.4 | 2.0 | 0.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.5 | 0.2 | 0.8 | 0.8 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -29791.7 | -278.3 | -197.3 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 3.4 | 2.4 | 3.2 | 2.9 | 1.5 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.76 | $2.80 | $4.22 | $7.30 | $3.56 | · | · | |
| Cash Flow / Share | $-0.13 | $0.07 | $-0.24 | $-0.43 | $-0.68 | · | · | |
| EPS (TTM) | $-0.46 | $-0.46 | $-0.44 | $-0.71 | $-1.42 | $-1.54 | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 40.3% | 8.8% | 15.0% | -25.5% | 118.8% | · | · | |
| Revenue CAGR 3Y | 20.6% | -2.3% | 23.3% | · | · | · | · | |
| Revenue CAGR 5Y | 23.4% | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | · | |
| Net Income TTM | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | · | |
| P/E | -5.1 | -6.8 | -2.2 | -1.3 | -2.6 | -10.9 | · | |
| Earnings Yield | -19.6% | -14.6% | -46.2% | -76.3% | -38.2% | -9.2% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $749M | $488M | $497M | $478M | $462M | $337M | $331M | $356M | $347M | $306M | $320M | $322M | $857M | $847M | $874M | |
| Gross Profit | · | · | · | · | · | · | · | $81M | $108M | $82M | $70M | $76M | $47M | $17M | $-12M | $13M | |
| SG&A Expense | $70M | $75M | $66M | $49M | $48M | $51M | $52M | $35M | $44M | $45M | $41M | $42M | $58M | $48M | $47M | $58M | |
| Operating Expenses | $715M | $722M | $537M | $521M | $488M | $464M | $358M | $340M | $349M | $370M | $340M | $349M | $402M | $931M | $949M | $962M | |
| Operating Income | $28M | $27M | $-49M | $-24M | $-11M | $-1M | $-21M | $-9M | $7M | $-23M | $-34M | $-29M | $-80M | $-74M | $-103M | $-87M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $0 | $7.0K | $0 | $404.0K | $390.0K | $403.0K | |
| Net Income | $28M | $27M | $-49M | $-24M | $-11M | $-1M | $-22M | $-9M | $7M | $-19M | $-41M | $-29M | $-73M | $-75M | $-104M | $-75M | |
| EPS (Basic) | $0.05 | $0.05 | · | · | $-0.02 | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | |
| EPS (Diluted) | $0.05 | $0.05 | · | · | $-0.02 | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | |
| Shares (Basic) | 524,186,885 | 522,184,385 | · | 512,743,521 | 509,043,210 | 497,056,331 | · | 490,180,103 | 487,483,087 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | |
| Shares (Diluted) | 545,447,735 | 532,501,448 | · | 512,743,521 | 509,043,210 | 497,056,331 | · | 490,180,103 | 495,179,955 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | |
| EBITDA | $28M | $27M | · | $-24M | $-11M | $-2M | · | $-9M | $7M | $-23M | $-41M | $-29M | $-74M | · | $-103M | $-87M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $78M | · | · | · | $195M | $288M | $255M | $208M | $299M | $310M | $191M | $383M | $324M | $274M | |
| Prepaid Expense | $19M | $18M | $18M | $12M | $15M | $17M | $13M | $13M | $15M | $17M | $15M | $15M | $17M | $18M | $20M | $22M | |
| Other Current Assets | $20M | $23M | $11M | $12M | $15M | $16M | $16M | $3M | $4M | $5M | $1M | $3M | $3M | $37M | $26M | $17M | |
| Current Assets | $485M | $448M | $308M | $331M | $363M | $331M | $343M | $433M | $550M | $553M | $916M | $1.13B | $1.27B | $1.46B | $1.86B | $2.49B | |
| PP&E (Net) | $7M | $7M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $3M | $2M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $8M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $25M | $25M | $24M | $27M | $16M | $14M | $13M | $11M | $10M | $10M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Total Assets | $720M | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | |
| Accounts Payable | $35M | $39M | $36M | $33M | $34M | $31M | $35M | $26M | $40M | $35M | $35M | $40M | $47M | $38M | $30M | $27M | |
| Current Liabilities | $323M | $337M | $209M | $193M | $202M | $216M | $214M | $280M | $325M | $356M | $719M | $908M | $1.11B | $1.13B | $1.60B | $2.15B | |
| Capital Leases | · | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $23M | $25M | $29M | $32M | $26M | $29M | $22M | $20M | $16M | $16M | $16M | $13M | $13M | $13M | |
| Total Liabilities | $344M | $358M | $232M | $219M | $231M | $248M | $240M | $311M | $349M | $379M | $738M | $927M | $1.13B | $1.17B | $1.64B | $2.19B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | $20M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | |
| Paid-in Capital | $2.71B | $2.70B | $2.68B | $2.66B | $2.63B | $2.60B | $2.58B | $2.55B | $2.52B | $2.49B | $2.43B | $2.40B | $2.36B | $2.28B | $2.24B | $2.20B | |
| Retained Earnings | $-2.23B | $-2.26B | $-2.29B | $-2.24B | $-2.21B | $-2.20B | $-2.20B | $-2.18B | $-2.17B | $-2.18B | $-2.09B | $-2.05B | $-2.02B | $-1.87B | $-1.80B | $-1.69B | |
| Treasury Stock | $96M | $94M | $86M | $77M | $71M | $63M | $31M | $24M | $19M | $16M | $12M | $10M | $9M | $6M | $6M | $6M | |
| AOCI | $-2M | $-672.0K | $528.0K | $471.0K | $177.0K | $-74.0K | $-2M | $852.0K | $-2M | $-3M | $-5M | $-7M | $-7M | $-11M | $-8M | $-7M | |
| Stockholders' Equity | $376M | $339M | $309M | $341M | $344M | $336M | $341M | $342M | $325M | $292M | $322M | $331M | $323M | $392M | $427M | $490M | |
| Liabilities + Equity | $720M | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 477,403,782 | · |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-428.0K | $-441.0K | $-501.0K | $-396.0K | $-509.0K | $-437.0K | $-384.0K | $-522.0K | $-947.0K | $-671.0K | $-954.0K | $-930.0K | $-3M | $-695.0K | $-18.0K | $-17.0K | |
| Stock-based Comp | $9M | $12M | $25M | $26M | $26M | $26M | $30M | $28M | $28M | $29M | $33M | $36M | $39M | $43M | $42M | $41M | |
| Restructuring | · | · | · | · | · | · | · | $-538.0K | $473.0K | $353.0K | $1M | $5M | $2M | · | · | · | |
| Other Non-cash | · | $69M | · | · | · | $-41M | · | · | · | $17M | · | · | $114M | · | · | $-22M | |
| Operating Cash Flow | $25M | $108M | $-68M | $12M | $5M | $-16M | $-86M | $50M | $45M | $26M | $-19M | $53M | $79M | $102M | $-39M | $-57M | |
| CapEx | $682.0K | $854.0K | $597.0K | $692.0K | $569.0K | $185.0K | $315.0K | $399.0K | $397.0K | $445.0K | $243.0K | $354.0K | $251.0K | $259.0K | $173.0K | $158.0K | |
| Investing Cash Flow | $-32.0K | $-5M | $-35M | $-5M | $36M | $9M | $-1M | $-12M | $5M | $9M | $-20M | $66M | $10M | $-43M | $89M | $37M | |
| Stock Issued | · | · | $541.0K | $0 | · | · | $193.0K | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $0 | $0 | $1.0K | $0 | $18M | $0 | $0 | $-2M | $0 | $-3M | $-3M | $3M | $276.0K | $105.0K | $6M | |
| Net Stock Activity | · | $0 | · | · | · | $-18M | · | · | · | $-3M | · | · | $-3M | · | · | $-6M | |
| Financing Cash Flow | $416.0K | $-8M | $-9M | $-5M | $-8M | $-32M | $-6M | $-5M | $-3M | $-3M | $-2M | $-147.0K | $-2M | $132.0K | $458.0K | $-6M | |
| Net Change in Cash | $26M | $95M | $-112M | $1M | $33M | $-39M | $-93M | $33M | $47M | $32M | $-41M | $120M | $87M | $58M | $51M | $-26M | |
| Free Cash Flow | · | $107M | · | · | · | $-16M | · | · | · | $25M | · | · | $79M | · | · | $-57M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 24.5% | 30.3% | 23.6% | 13.1% | 14.9% | 10.5% | · | -1.4% | 1.5% | |
| Operating Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.6% | 2.0% | -6.5% | -8.6% | -5.6% | -13.8% | · | -12.1% | -10.0% | |
| Net Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.8% | 2.1% | -5.5% | -8.6% | -5.6% | -13.8% | · | -12.3% | -8.6% | |
| EBITDA Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.37% | · | -2.6% | 2.0% | -6.7% | -8.6% | -5.6% | -13.9% | · | -12.1% | -10.0% | |
| ROA | 4.3% | 4.3% | · | -4.0% | -1.7% | -0.20% | · | -1.1% | 0.77% | -1.8% | -3.2% | -1.7% | -3.5% | · | -6.3% | -4.2% | |
| ROE | 7.8% | 8.1% | · | -7.1% | -3.2% | -0.41% | · | -2.8% | 2.3% | -6.2% | -11.6% | -7.6% | -17.9% | · | -28.2% | -14.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.3 | · | 1.7 | 1.8 | 1.5 | · | 1.5 | 1.7 | 1.6 | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.2 | |
| Quick Ratio | · | · | · | · | · | · | · | 1.0 | 0.8 | 0.6 | 0.4 | 0.3 | 0.2 | · | 0.2 | 0.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4115.3 | · | · | -262.9 | -216.6 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.7 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 | · | 0.5 | 0.5 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.89 | · | |
| Revenue / Share | $1.36 | $1.41 | · | $0.97 | $0.94 | $0.93 | · | $0.68 | $0.72 | $0.71 | $1.00 | $1.07 | $1.10 | · | $1.78 | $1.85 | |
| Cash Flow / Share | · | $0.20 | · | · | · | $-0.03 | · | · | · | $0.05 | · | · | $0.17 | · | · | $-0.12 | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.68 | · | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.97 | $-0.89 | $-1.45 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.21B | · | $1.77B | $1.61B | $1.49B | · | $1.35B | $1.32B | $1.29B | $-533M | $18M | $544M | $3.01B | $2.58B | $2.15B | |
| Net Income TTM | $-18M | $-57M | · | $-58M | $-43M | $-25M | · | $-91M | $-124M | $-160M | $-227M | $-261M | $-337M | $-443M | $-402M | $-615M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.02B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $717M | · | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.8 | -2.4 | -2.4 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.4 | · | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | · | · | -57.1% | -41.6% | -40.8% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Ricavi | $1.92B | $1.37B | $1.26B | · | · |
| Margine Lordo % | · | · | 12.7% | · | · |
| Margine Operativo % | -4.4% | -3.3% | -10.2% | · | · |
| Utile netto | $-86M | $-43M | $-213M | · | · |
| EPS Diluito | · | · | $-0.44 | · | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Rapporto corrente | 1.5 | 1.6 | 1.6 | · | · |
| Quick Ratio | 0.4 | 0.9 | 0.5 | · | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-69M | $33M | $-116M | · | · |
Proprietari istituzionali (13F) 247 filer · $880.9M totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
247
Valore detenuto
$880.9M
Nuove posizioni
43
Posizioni chiuse
25
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 43 (-6 vs trimestre precedente) | 25 (+3 vs trimestre precedente) | 84 (+28 vs trimestre precedente) | 57 (-5 vs trimestre precedente) | +24.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $183.960.495 | 35.106.965 | 20,88% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $94.517.344 | 18.037.661 | 10,73% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $56.844.123 | 10.846.066 | 6,45% | Azioni |
| VANGUARD GROUP INC | $55.191.894 | 23.485.912 | 6,27% | Azioni |
| STATE STREET CORP | $53.344.966 | 10.180.337 | 6,06% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $37.756.296 | 7.205.400 | 4,29% | Opzione Call |
| Nuveen, LLC | $32.968.503 | 6.291.699 | 3,74% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28.931.025 | 5.521.188 | 3,28% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23.425.168 | 4.470.452 | 2,66% | Azioni |
| NORTHERN TRUST CORP | $19.768.424 | 3.772.600 | 2,24% | Azioni |
| PNC Financial Services Group, Inc. | $18.674.700 | 3.563.874 | 2,12% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $16.501.126 | 3.148.626 | 1,87% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $15.300.239 | 2.919.893 | 1,74% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $14.710.991 | 2.807.441 | 1,67% | Azioni |
| MORGAN STANLEY | $12.022.159 | 2.294.305 | 1,36% | Azioni |
| CITADEL ADVISORS LLC | $11.335.194 | 2.163.205 | 1,29% | Azioni |
| D. E. Shaw & Co., Inc. | $10.299.183 | 1.965.493 | 1,17% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.456.104 | 1.804.600 | 1,07% | Opzione Put |
| MARSHALL WACE, LLP | $8.191.111 | 1.563.189 | 0,93% | Azioni |
| Invesco Ltd. | $7.004.779 | 1.336.790 | 0,80% | Azioni |
| GMT Capital Corp | $6.839.248 | 1.305.200 | 0,78% | Azioni |
| MACKENZIE FINANCIAL CORP | $6.798.774 | 1.297.476 | 0,77% | Azioni |
| JANE STREET GROUP, LLC | $6.767.161 | 1.291.443 | 0,77% | Azioni |
| Cerity Partners LLC | $6.460.322 | 1.232.886 | 0,73% | Azioni |
| CAXTON ASSOCIATES LLP | $6.375.146 | 1.216.631 | 0,72% | Azioni |
| Bank of New York Mellon Corp | $6.346.194 | 1.211.106 | 0,72% | Azioni |
| CITADEL ADVISORS LLC | $6.236.124 | 1.190.100 | 0,71% | Opzione Put |
| GOLDMAN SACHS GROUP INC | $6.134.688 | 1.170.742 | 0,70% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $5.809.698 | 1.108.721 | 0,66% | Azioni |
| Point72 Asset Management, L.P. | $5.604.940 | 1.069.645 | 0,64% | Azioni |
| CITADEL ADVISORS LLC | $5.373.096 | 1.025.400 | 0,61% | Opzione Call |
| JANE STREET GROUP, LLC | $4.378.020 | 835.500 | 0,50% | Opzione Call |
| Swiss National Bank | $4.315.140 | 823.500 | 0,49% | Azioni |
| GROUP ONE TRADING LLC | $3.915.532 | 747.239 | 0,44% | Azioni |
| IMC-Chicago, LLC | $3.369.477 | 643.030 | 0,38% | Azioni |
| WOLVERINE TRADING, LLC | $3.096.288 | 992.400 | 0,35% | Opzione Call |
| TUDOR INVESTMENT CORP ET AL | $2.808.116 | 535.900 | 0,32% | Opzione Call |
| RHUMBLINE ADVISERS | $2.726.870 | 520.397 | 0,31% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $2.558.074 | 488.182 | 0,29% | Azioni |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2.528.269 | 482.494 | 0,29% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.421.577 | 462.133 | 0,27% | Azioni |
| DEUTSCHE BANK AG\ | $2.309.776 | 440.797 | 0,26% | Azioni |
| UBS Group AG | $2.145.519 | 409.450 | 0,24% | Azioni |
| WELLS FARGO & COMPANY/MN | $2.070.099 | 395.057 | 0,24% | Azioni |
| Legal & General Group Plc | $2.032.108 | 387.807 | 0,23% | Azioni |
| ALGERT GLOBAL LLC | $1.965.419 | 375.080 | 0,22% | Azioni |
| PEAK6 LLC | $1.954.520 | 373.000 | 0,22% | Opzione Call |
| BANK OF AMERICA CORP /DE/ | $1.860.273 | 355.014 | 0,21% | Azioni |
| JPMORGAN CHASE & CO | $1.673.457 | 296.369 | 0,19% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.607.129 | 306.704 | 0,18% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| ChaChaCha SPAC C LLC, Chamath Palihapitiya | 04 Ottobre 2022 | · | Deposito iniziale | · | SEC |
| SCH Sponsor III LLC, ChaChaCha SPAC C LLC, Chamath Palihapitiya, Ian Osborne ×2 depositi | 14 Gennaio 2022 | · | Deposito iniziale | · | SEC |
| Vivek Garipalli | 19 Gennaio 2021 | · | Deposito iniziale | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 29 insider · 15 dirigenti · 12 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrew Toy | Chief Executive Officer | 01 Ottobre 2026 S | 9.140.510 | 0 | 4 | $-3.704.610 |
| Jamie L. Reynoso | CEO, Medicare Advantage | 17 Settembre 2026 S | 2.803.446 | 0 | 16 | $-456.213 |
| Conrad Wai | CEO, Counterpart Health | 15 Settembre 2026 S | 1.170.056 | 0 | 3 | $-2.408.584 |
| Brady Patrick Priest | CEO of Clover Care Services | 13 Maggio 2026 S | 2.040.222 | 0 | 2 | $-724.847 |
| Aric R Sharp | CEO of Value Based Care | 09 Agosto 2024 F | 2.100.665 | 0 | 0 | $0 |
| Joseph Clay Thornton | Interim CFO | 17 Agosto 2026 S | 1.249.526 | 0 | 2 | $-99.654 |
| Peter J. Kuipers | Chief Financial Officer | 29 Gennaio 2026 F | 5.758.353 | 0 | 0 | $0 |
| Scott J. Leffler | Chief Financial Officer | 25 Gennaio 2024 F | 4.857.303 | 0 | 0 | $0 |
| Joseph F. Wagner | Chief Financial Officer | 09 Agosto 2021 C | 25.000 | 0 | 0 | $0 |
| Joseph Frank Oldakowski | VP OF FINANCE AND CONTROLLER | 16 Settembre 2026 S | 275.897 | 0 | 3 | $-176.725 |
| Karen Soares | Chief Legal Officer | 15 Settembre 2026 S | 1.607.371 | 0 | 4 | $-336.594 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | Chief Technology Officer | 31 Ottobre 2023 A | 3.093.225 | 0 | 0 | $0 |
| Joseph Richards Martin | General Counsel | 14 Giugno 2023 F | 2.718.857 | 0 | 0 | $0 |
| Prabhdeep Singh | Chief Growth Officer | 16 Settembre 2022 A | 872.821 | 0 | 0 | $0 |
| Gia Lee | General Counsel & Secretary | 07 Gennaio 2021 A | · | 0 | 0 | $0 |
| Brian James Miller | Direttore | 30 Settembre 2026 A | 12.481 | 0 | 0 | $0 |
| Robert G Torricelli | Direttore | 30 Settembre 2026 A | 186.897 | 0 | 0 | $0 |
| Carladenise Armbrister Edwards | Direttore | 18 Maggio 2026 S | 285.432 | 0 | 1 | $-229.687 |
| Vivek Garipalli | Direttore | 07 Gennaio 2026 M | 1.856.247 | 0 | 0 | $0 |
| Anna U Loengard | Direttore | 06 Gennaio 2026 A | 527.456 | 0 | 0 | $0 |
| Demetrios L. Kouzoukas | Direttore | 06 Gennaio 2026 A | 605.980 | 0 | 0 | $0 |
| William G Robinson Jr | Direttore | 06 Gennaio 2026 A | 597.987 | 0 | 0 | $0 |
| Thomas L Tran | Direttore | 06 Gennaio 2026 A | 180.029 | 0 | 0 | $0 |
| Chelsea Clinton | Direttore | 06 Gennaio 2025 A | 602.814 | 0 | 0 | $0 |
| Lee Shapiro | Direttore | 06 Gennaio 2025 A | 598.622 | 0 | 0 | $0 |
| Nathaniel S. Turner | Direttore | 07 Gennaio 2021 A | · | 0 | 0 | $0 |
| Ian Osborne | Proprietario del 10% | 07 Gennaio 2021 M | 25.500.000 | 0 | 0 | $0 |
| James Ryans | · | 07 Gennaio 2021 M | 100.000 | 0 | 0 | $0 |
| Jacqueline D Reses | · | 07 Gennaio 2021 M | 300.000 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 25 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 0,88% | 601.135 SH | 02 Ottobre 2026 | Giornaliero |
| IHF · iShares Trust | 0,28% | 778.656 SH | 11 Settembre 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,25% | 158.213 SH | 02 Ottobre 2026 | Giornaliero |
| IWO · iShares Trust | 0,13% | 3.960.261 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 451.034 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 636.652 SH | 02 Ottobre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 2.420.762 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,07% | 10.919.497 SH | 11 Settembre 2026 | Giornaliero |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 109.827 NS | 31 Luglio 2026 | N-PORT |
| RSSL · Global X Funds | 0,06% | 201.395 NS | 31 Luglio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,03% | 1.226.414 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 193.636 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 4.645.340 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,02% | 23.436 SH | 11 Settembre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 502.203 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 615.231 SH | 11 Settembre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,00% | 23.911 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 109.551 SH | 11 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 228.838 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 21.592 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 486 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 12.982.885 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 34.580 SH | 19 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | · | 19.297 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 91.976 SH | 11 Settembre 2026 | Giornaliero |
CLOV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 10 analisti
COMPRA
Target mediano
$5.25
+19,9%
2 20,0%
Acquisto forte
4 40,0%
Compra
4 40,0%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
4 analisti · 2026-09-30Target medio $5.38 +22,7%
← Sotto tutti i target
Prezzo attuale $4.38
Basso$5.00
Media$5.38
Alto$6.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 7, 2026